Janus Henderson Mid Cap Value I (JMVAX)

Nasdaq Currently unchanged in today's trading session

1 member of Congress has disclosed 6 trades in Janus Henderson Mid Cap Value I (JMVAX) via STOCK Act filings. The most recent disclosure was a purchase by Brian Babin on 10 December 2025. Aggregate disclosed activity totals roughly $40K in purchases and $8K in sales (midpoint estimates from bracketed disclosure amounts).

Janus Henderson Mid Cap Value I is currently trading at $17.18, positioned at 88% of its 52-week range ($14.82 – $17.49).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$17.18
24h Change
0.00 (0.00%)
52 Week Range
$14.82$17.49
View on NASDAQ

Janus Henderson Mid Cap Value I Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for JMVAX

Select to highlight on chart
1 transactions
Compliance: 17%
Brian Babin29 Jun 20165 Aug 2016PurchaseStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$3.83B

Volume

0

Beta

0.81

P/E Ratio

5.76

Fundamentals

EPS

$2.98

Div. Yield

8.67%

Open

$17.18

Day Range

$17.18 — $17.18

Company Information

Sector
Financial Services
Industry
Asset Management
Exchange
NASDAQ · USD
Country
US
IPO Date
2005-11-30

The Janus Henderson Mid Cap Value Fund primarily seeks investment opportunities in mid-sized companies whose stock prices, in the view of its portfolio managers, are currently undervalued. A significant portion of the fund's capital, specifically at...

No earnings data available for this stock.

Dividends

Dividend History

9 Dec 2025
Amount $1.4894
10 Dec 2024
Amount $0.1400
11 Dec 2023
Amount $0.1910
22 Dec 2022
Amount $0.1950
22 Dec 2021
Amount $0.1090
21 Dec 2020
Amount $0.1757
19 Dec 2019
Amount $0.1710
20 Dec 2018
Amount $0.1950
21 Dec 2017
Amount $0.0820
21 Dec 2016
Amount $0.1450
21 Dec 2015
Amount $0.2740
22 Dec 2014
Amount $5.4935
19 Dec 2013
Amount $0.3950
20 Dec 2012
Amount $0.1660
22 Dec 2011
Amount $0.3530
20 Dec 2010
Amount $0.2020
18 Dec 2009
Amount $0.0596
30 Jun 2009
Amount $0.1497

Stock Splits

Split History

6 Jul 2009Reverse Split
Ratio8551:10000

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about JMVAX

Which members of Congress have traded JMVAX?
1 member of Congress has disclosed 6 trade in Janus Henderson Mid Cap Value I (JMVAX) under the STOCK Act: Brian Babin.
When was JMVAX most recently disclosed by Congress?
The most recent JMVAX disclosure was a purchase by Brian Babin on 10 December 2025.
What is the total disclosed congressional trading volume for JMVAX?
Members of Congress have disclosed approximately $40K in JMVAX purchases and $8K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in JMVAX?
This JMVAX page updates as soon as new STOCK Act disclosures are filed for Janus Henderson Mid Cap Value I. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.